Joan Connolly

Executive

CA·SEDI

enGene Therapeutics Inc.

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 19 Jun 2026 for enGene Therapeutics Inc., €216k. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Joan Connolly: trading record in brief

One trade, one date: on 19 June 2026, Joan Connolly disclosed an option exercise of €216k in enGene Therapeutics Inc. No broader history exists yet. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Joan Connolly

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

enGene Therapeutics Inc. (CA)

Declarations1 total

◇

Joan Connolly

5 - Senior Officer of IssuerExecutives16 Jun 2026enGene Therapeutics Inc.

350,000 CAD19SEDI ↗

200,000 shares@ CA$1.75100.0% of flowOptionsTSXSEDI:4737770

1 of 1 declaration

Joan Connolly

Insider track record

Joan Connolly: trading record in brief

Companies and markets linked to Joan Connolly

Related entities

Joan Connolly

Insider track record

Joan Connolly: trading record in brief

Companies and markets linked to Joan Connolly

Related entities